aamc.org does not support this web browser.

Washington Highlights

pharmacist
Washington Highlights
AAMC-Supported House Letter Urges Enforcement Action Against J&J for Proposed Rebate Model

Nearly 200 bipartisan House members sent a Sept. 30 letter to the HHS Secretary with concern over Johnson & Johnson’s proposal to convert 340B into a rebate mod

  • Oct. 4, 2024

Washington Highlights is a weekly newsletter that provides updates on the latest legislative and regulatory activities affecting medical schools, teaching hospitals, and their patients and communities.

Recent Articles

""
Washington Highlights
AAMC Joins Letter Opposing NDAA Provision Limiting Animal Research

The AAMC joined a Sept. 30 group letter urging lawmakers to oppose an NDAA provision limiting animal research.

  • Oct. 4, 2024
A researcher in a lab scans lab equipment
Washington Highlights
AAMC Submits Letter to FDA on Clinical Trial Diversity Action Plans

The AAMC on Sept. 26 responded to the FDA’s draft guidance on Diversity Action Plans to improve enrollment in clinical trials.

  • Oct. 4, 2024
A group of diverse women medical providers with masks
Washington Highlights
AAMC Comments on ONC’s HTI-2 Proposed Rule

The AAMC submitted comments Oct. 4 to the HHS ASTP/ONC’s second Health Data, Technology, and Interoperability (HTI) proposed rule.

  • Oct. 4, 2024
Doctors in a meeting at hospital
Washington Highlights
Johnson & Johnson Withdraws Proposed 340B Rebate Model

After HRSA sent a second letter threatening enforcement action, Johnson & Johnson withdrew its proposed rebate model for two 340B drugs.

  • Oct. 4, 2024
Blurred shot of doctors working in a busy hospital corridor
Washington Highlights
CMS Issues Interim Final Rule Withdrawing Low Wage Index Policy for FY25

In an interim final rule on the FY 2025 Inpatient Prospective Payment System, the CMS withdrew its low wage index policy for fiscal year 2025.

  • Oct. 4, 2024
pill bottles
Washington Highlights
CMS Finalizes Medicaid Drug Rebate Program Rule With 340B Implications

The CMS finalized a rule related to the Medicaid Drug Rebate Program, which includes changes to the definition of covered outpatient drug.

  • Sept. 27, 2024

Other Washington Highlights Articles

More
91-aamc-news-gun-violence-hero.jpg__992x558_q85_crop-smart_subsampling-2_upscale
Washington Highlights
White House Announces Executive Actions Enhancing Gun Violence Prevention

The White House announced Sept. 26 executive actions through several federal agencies intended to enhance gun violence prevention.

  • Sept. 27, 2024
Healthcare workers meeting
Washington Highlights
President Signs Continuing Resolution to Fund Government Through Dec. 20

President Joe Biden on Sept. 26 signed a continuing resolution to fund the government through Dec. 20.

  • Sept. 27, 2024
Two researchers wearing lab coats and eye protection analyze a sample in a laboratory.
Washington Highlights
Senate Committee Advances Risky Research Review Act

The Senate Homeland Security and Governmental Affairs Committee advanced the Risky Research Review Act along a bipartisan vote.

  • Sept. 27, 2024
Rotunda_1200x666

Scheduled hearings and meetings related to academic medicine.

Read On the Agenda In Washington

testimony and correspondence graphic

Find congressional testimony, letters to Capitol Hill and federal agencies, and comment letters on policy issues.

Read Testimony and Correspondence

Contact the AAMC Office of Government Affairs Staff

Email Us